ClinicalTrialsFinder

Membranoproliferative Glomerulonephritis Clinical Trials in Asahikawa, Hokkaido

1 recruitingAsahikawa, Hokkaido, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 3

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals225 enrolled50 locationsNCT03955445